The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...

In industry parlance, the deal joins a “delivery” company with a “cargo” company — fusing the two key pieces needed to build ...

Chroma, a startup building a new type of audiovisual entertainment for mobile devices, has been sold. The company, which had financial backing from Twitter and Medium co-founder Biz Stone as well ...

Two Boston-area biotechs are shedding staff and merging together to form a new genetic medicines company. | Chroma Medicines ...

Chroma Ate designs and manufactures precision ... and electric vehicles industries. Founded in 1984, the company is headquartered in Taoyuan, Taiwan.

The new company has also raised $75 million that will support the development of epigenetic editing therapies for hepatitis B ...

The merger of Nvelop Therapeutics and Chroma Medicine brings together a combination of epigenetic editing and in vivo ...

Chroma Medicine and Nvelop Therapeutics have merged to form nChroma Bio, the companies announced Wednesday. Alongside the launch of the genetic medicines company, nChroma also announced a $75 ...